Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scientific conference funding

This article was originally published in The Tan Sheet

Executive Summary

FDA will continue to partially support scientific conferences by awarding limited number of grants each fiscal year ranging from $1,000-$25,000 in direct costs per conference, FDA announces in June 6 Federal Register. Agency notes applications will be "reviewed and evaluated for their scientific and technical merit by an ad hoc review panel" that will consider content/subject matter of conference in relation to agency's mission, conference plan, experience of principal investigator/director. FDA requests plans address specific objectives of "Healthy People 2010"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094132

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel